Hypo-RESOLVE

Hypoglycaemia - REdefining SOLutions for better liVEs
Hypo-RESOLVE logo

FACTS & FIGURES

Start Date
End Date
Call
IMI2 - Call 10
Grant agreement number
777460

Type of Action: 
RIA (Research and Innovation Action)

Contributions
IMI Funding
13 450 057
EFPIA in kind
10 316 000
Associated Partners
3 008 525
Total Cost
26 774 583

Summary

Many diabetes patients experience hypoglycaemia, when their blood sugar levels become too low. Symptoms include behavioural changes, memory loss and confusion, which can result in accidents and falls and, in the worst cases, in hospitalisation or death. Worries about hypoglycaemia represent a serious psychological burden for people with diabetes.

Despite its seriousness, little is known about hypoglycaemia. The Hypo-RESOLVE project aims to change that by adding to our understanding of the underlying causes of the condition, as well as its predictors and consequences. They will also analyse the financial costs of hypoglycaemia. Ultimately, the hope is that the project results will pave the way for new, better treatments for people with diabetes that will help them to maintain healthy blood sugar levels.

Participants Show participants on map

EFPIA companies
  • Abbott Diabetes Care, Alameda, United States
  • Eli Lilly and Company Limited, Basingstoke, United Kingdom
  • Medtronic International Trading SARL, Tolochenaz, Switzerland
  • Novo Nordisk A/S, Bagsvaerd, Denmark
  • Sanofi-Aventis Deutschland GMBH, Frankfurt / Main, Germany
Universities, research organisations, public bodies, non-profit groups
  • Centre Hospitalier Universitaire Montpellier, Montpellier, France
  • King'S College London, London, United Kingdom
  • Medizinische Universitat Graz, Graz, Austria
  • Region Hovedstaden, Hilleroed, Denmark
  • SIB Institut Suisse De Bioinformatique, CH-660-0733998-3, Genève, Switzerland
  • Stichting Katholieke Universiteit, Nijmegen, Netherlands
  • Syddansk Universitet, Odense, Denmark
  • The University Of Edinburgh, Edinburgh, United Kingdom
  • The University Of Sheffield, Sheffield, United Kingdom
  • Universita Degli Studi Di Padova, Padova, Italy
  • Universite De Lausanne, Lausanne, Switzerland
  • University Of Dundee, Dundee, United Kingdom
  • University of Cambridge, Cambridge, United Kingdom
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
  • Eurice European Research And Project Office GMBH, Saarbrücken, Germany
Associated partners
  • Federation Internationale Du Diabete, Brussels, Belgium
  • Jdrf International, New York, United States
  • The Leona M. And Harry B. Helmsley Charitable Trust, New York, United States
  • Unitio Inc, Boston, United States

CONTACT

Project coordinator
Bastiaan DE GALAN
STICHTING KATHOLIEKE UNIVERSITEIT
bastiaan.degalan[at]radboudumc.nl
Project leader
Stephen GOUGH
NOVO NORDISK
secg[at]novonordisk.com
Project co-leader
Matthias MÜLLENBORN
NOVO NORDISK
zmul[at]novonordisk.com